Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction.
Abelin JG, Harjanto D, Malloy M, Suri P, Colson T, Goulding SP, Creech AL, Serrano LR, Nasir G, Nasrullah Y, McGann CD, Velez D, Ting YS, Poran A, Rothenberg DA, Chhangawala S, Rubinsteyn A, Hammerbacher J, Gaynor RB, Fritsch EF, Greshock J, Oslund RC, Barthelme D, Addona TA, Arieta CM, Rooney MS.
Abelin JG, et al. Among authors: mcgann cd.
Immunity. 2021 Feb 9;54(2):388. doi: 10.1016/j.immuni.2020.12.005.
Immunity. 2021.
PMID: 33567264
Free article.
No abstract available.